ID: uc010bnp.1_intron_4_0_chr15_89804973_f
GENE: FANCI(5)
chr15:89804923-89805101+


(3)
B-CELL
(1)
BREAST
(8)
CELL-LINE
(4)
HELA
(1)
LIVER
(1)
OTHER
(2)
SKIN
(1)
XRN.ip

Sense strand
CATTCTCACTGCCCTGGCTACGAAAAAGGAAAATCTGGCTTATGGAAAAGGTAATTTTCTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGCATTTCTAGGTGTACTGAGTGGGGAAGAATGTAAGAAACAGTTGATTAACACCCTGTGT
..................................................(((((..((....)).....(((((...........)).)))..........)))))........................................................................
..................................................51.........................................................110...................................................................
SizePerfect hitTotal NormPerfect NormDRR001485(DRX001039)
"Hela long total cell fraction, LNA(+)". (hela)
DRR001486(DRX001040)
"Hela long cytoplasmic cell fraction, LNA(+)". (hela)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
DRR001482(DRX001036)
"Hela long total cell fraction, control". (hela)
SRR033715(GSM497060)
Mantle Cell Lymphoma (Mino122). (B cell)
SRR037944(GSM510482)
293DcrTN_cand5. (cell line)
DRR001487(DRX001041)
"Hela long nuclear cell fraction, LNA(+)". (hela)
SRR189784SRR037936(GSM510474)
293cand1. (cell line)
DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)
SRR553572(SRX182778)
source: Frontal Cortex. (Frontal Cortex)
SRR191607(GSM715717)
192genomic small RNA (size selected RNA from . (breast)
SRR330885(SRX091723)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR033724(GSM497069)
L428 cell line (L428). (B cell)
SRR189782SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)
SRR039612(GSM531975)
Human Normal Liver Tissue Sample 2. (liver)
SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR029130(GSM416759)
DLD2. (cell line)
SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
..................................................GTAATTTTCTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGCATTTCTAG..................................................79181.0081.0054.0023.00-2.00--2.00---------------
..................................................GTAATTTTCTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGAAAA.......................................................745.000.00-5.00--------------------
..........................................................CTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGCATTTCTAG..................................................7115.005.005.00---------------------
..................................................GTAATTTTCTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGCATTTCTAA..................................................794.000.00-4.00--------------------
.............................AAAATCTGGCTTATGGAAAAG.................................................................................................................................2112.002.00--2.00-------------------
.......................AAAAGGAAAATCTGGCTTATGGA.....................................................................................................................................2312.002.00-----2.00----------------
..................................................GTAATTTTCTTCCGACTTTAGTGGC........................................................................................................2511.001.00-------------1.00--------
.......................AAAAGGAAAATCTGGTGTT.........................................................................................................................................191.000.00-----------1.00----------
...................................TGGCTTATGGAAAAGGAGG.............................................................................................................................191.000.00-----------------1.00----
.................................TCTGGCTTATGGAAAAG.................................................................................................................................1711.001.00---------1.00------------
..................................................GTAATTTTCTTCCGACTTTAGTGGCTTT.....................................................................................................2811.001.00--------------------1.00-
..................TACGAAAAAGGAAAATCTGGCTT..........................................................................................................................................2311.001.00-------------------1.00--
........................................................TTCTTCCGACTTTAGTGGC........................................................................................................1911.001.00------------1.00---------
...............................................................................................................................AGGTGTACTGAGTGGGGAAGA...............................2111.001.00----1.00-----------------
...........................................................................................................................................TGGGGAAGAATGTAAGAAACAGTT................2411.001.00---------------1.00------
......................................................TTTTCTTCCGACTTTAGTGGCTTTCTCT.................................................................................................281.000.00------------------1.00---
...............................AATCTGGCTTATGGAAAAG.................................................................................................................................1911.001.00--1.00-------------------
.......................AAAAGGAAAATCTGGCTTATGGAAAAGGT...............................................................................................................................2911.001.00----------1.00-----------
..........................AGGAAAATCTGGCTTATGGAAAAG.................................................................................................................................2411.001.00--------1.00-------------
..........................................TGGAAAAGGTAATTTTATG......................................................................................................................191.000.00--------------1.00-------
........................................................................................ACATAATCAAATTCACCT.........................................................................181.000.00---------------------1.00
...........................................................................................................................................TGGGGAAGAATGTAAGAAA.....................1911.001.00----------------1.00-----
.............................AAAATCTGGCTTATGGAAAAGGT...............................................................................................................................2311.001.00--1.00-------------------
......................AAAAAGGAAAATCTGGCTTA.........................................................................................................................................2011.001.00----1.00-----------------

Antisense strand
CATTCTCACTGCCCTGGCTACGAAAAAGGAAAATCTGGCTTATGGAAAAGGTAATTTTCTTCCGACTTTAGTGGCTTTTTCTCTATGCACATAATCAAATTCATTGCTCAGTATATTTTGCATTTCTAGGTGTACTGAGTGGGGAAGAATGTAAGAAACAGTTGATTAACACCCTGTGT
..................................................(((((..((....)).....(((((...........)).)))..........)))))........................................................................
..................................................51.........................................................110...................................................................
SizePerfect hitTotal NormPerfect NormDRR001485(DRX001039)
"Hela long total cell fraction, LNA(+)". (hela)
DRR001486(DRX001040)
"Hela long cytoplasmic cell fraction, LNA(+)". (hela)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
DRR001482(DRX001036)
"Hela long total cell fraction, control". (hela)
SRR033715(GSM497060)
Mantle Cell Lymphoma (Mino122). (B cell)
SRR037944(GSM510482)
293DcrTN_cand5. (cell line)
DRR001487(DRX001041)
"Hela long nuclear cell fraction, LNA(+)". (hela)
SRR189784SRR037936(GSM510474)
293cand1. (cell line)
DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)
SRR553572(SRX182778)
source: Frontal Cortex. (Frontal Cortex)
SRR191607(GSM715717)
192genomic small RNA (size selected RNA from . (breast)
SRR330885(SRX091723)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR033724(GSM497069)
L428 cell line (L428). (B cell)
SRR189782SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)
SRR039612(GSM531975)
Human Normal Liver Tissue Sample 2. (liver)
SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR029130(GSM416759)
DLD2. (cell line)
SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
..........................................TGGAAAAGGTAATTTCATT...................................................................................................................... 191.000.00-------1.00--------------